Jushi Holdings (JUSHF) Operating Leases (2021 - 2022)

Jushi Holdings' (JUSHF) quarterly Operating Leases came in at $18.3 million in Q3 2022, down 7.45% on a QoQ basis from $19.8 million in Q2 2022.

Jushi Holdings (JUSHF) Operating Leases (2021 - 2022) Analysis & Trends

Jushi Holdings (JUSHF) has 2 years of Operating Leases data on file, last reported at $18.3 million in Q3 2022.

On a quarterly basis, Operating Leases changed N/A year-over-year to $18.3 million in Q3 2022; TTM through Sep 2022 was $18.3 million, a N/A change from a year earlier, with the FY2021 full-year figure at $15.2 million, changed N/A from the prior year.
Operating Leases for Q3 2022 stood at $18.3 million, down from $19.8 million in the prior quarter.
Over the last five years, Operating Leases for JUSHF reached as high as $19.8 million in Q2 2022 and fell as low as $15.2 million in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Jushi Holdings	81.25 Mn	41.54 Mn	29.88 Mn

Download Data